ALS Life Sciences Limited
ALS Life Sciences Limited, headquartered in Ireland (IE), is a prominent player in the global life sciences industry. Founded in 1976, the company has established itself as a leader in analytical testing and laboratory services, catering to a diverse range of sectors including pharmaceuticals, food and beverage, and environmental testing. With operational facilities across Europe, ALS Life Sciences offers a comprehensive suite of services, including microbiological testing, chemical analysis, and regulatory compliance support. Their commitment to quality and innovation sets them apart, ensuring clients receive accurate and timely results. Recognised for their expertise, ALS Life Sciences has achieved significant milestones, including numerous accreditations and partnerships that enhance their market position. Their dedication to scientific excellence and customer satisfaction continues to drive their success in the competitive life sciences landscape.
DitchCarbon Score
How does ALS Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Insurance Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ALS Life Sciences Limited's score of 38 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ALS Life Sciences Limited's reported carbon emissions
In 2023, ALS Life Sciences Limited reported total carbon emissions of approximately 11922000 kg CO2e for Scope 1, 54528000 kg CO2e for Scope 2, and a significant 460000000 kg CO2e for Scope 3 emissions. This represents a notable increase in Scope 3 emissions from 310000000 kg CO2e in 2022, while Scope 1 emissions decreased from 12320000 kg CO2e and Scope 2 emissions decreased from 56914000 kg CO2e in the previous year. The company has set ambitious climate commitments, aiming to reduce its Scope 1 and 2 emissions by 78% by 2030, starting from the 2023 baseline. Additionally, ALS Life Sciences Limited has a long-term goal to achieve net zero emissions across all scopes by 2050. These targets reflect the company's commitment to addressing climate change and reducing its carbon footprint. The emissions data is not cascaded from any parent organization, indicating that ALS Life Sciences Limited independently reports its emissions and climate initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 10,193,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 67,977,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ALS Life Sciences Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
